CSS
Cubist Systematic Strategies Portfolio holdings
AUM
$9.23B
1-Year Return
5.79%
This Quarter Return
+7.29%
1 Year Return
+5.79%
3 Year Return
+24.49%
5 Year Return
+69.08%
10 Year Return
+125.75%
AUM
$8.87B
AUM Growth
+$1.06B
(+14%)
Cap. Flow
+$537M
Cap. Flow
% of AUM
6.05%
Top 10 Holdings %
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,199
Closed
351
Top Buys
| 1 |
Okta
OKTA
|
+$37.7M |
| 2 |
Linde
LIN
|
+$31.1M |
| 3 |
Take-Two Interactive
TTWO
|
+$29.9M |
| 4 |
Walmart
WMT
|
+$25.8M |
| 5 |
Fiserv
FI
|
+$25.2M |
Top Sells
| 1 |
Aptiv
APTV
|
+$49.5M |
| 2 |
PayPal
PYPL
|
+$34.6M |
| 3 |
Apple
AAPL
|
+$33.1M |
| 4 |
NVIDIA
NVDA
|
+$31.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$30M |
Sector Composition
| 1 | Technology | 18.42% |
| 2 | Consumer Discretionary | 15.91% |
| 3 | Healthcare | 13.86% |
| 4 | Industrials | 12.32% |
| 5 | Financials | 11.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
First Solar
FSLR
$21.4B
| $32K | ﹤0.01% |
355
-2,640
| -88% | -$238K |
|
2827
International Flavors & Fragrances
IFF
$16.8B
| $31K | ﹤0.01% |
210
-6,907
| -97% | -$1.02M |
|
2828
Navigator Holdings
NVGS
$1.11B
| $30K | ﹤0.01% |
+2,737
| New | +$30K |
|
|
GRA
2829
DELISTED
W.R. Grace & Co.
GRA
| $30K | ﹤0.01% |
438
-53,691
| -99% | -$3.68M |
|
2830
Sprinklr
CXM
$1.91B
| $29K | ﹤0.01% |
+1,400
| New | +$29K |
|
2831
Denison Mines
DNN
$2.17B
| $29K | ﹤0.01% |
+23,700
| New | +$29K |
|
2832
Fulcrum Therapeutics
FULC
$393M
| $29K | ﹤0.01% |
2,795
-860
| -24% | -$8.92K |
|
2833
Nautilus Biotechnolgy
NAUT
$85.5M
| $28K | ﹤0.01% |
+2,750
| New | +$28K |
|
|
KDNY
2834
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $28K | ﹤0.01% |
+1,991
| New | +$28K |
|
2835
Mirum Pharmaceuticals
MIRM
$3.83B
| $28K | ﹤0.01% |
1,618
-6,641
| -80% | -$115K |
|
2836
Iovance Biotherapeutics
IOVA
$858M
| $27K | ﹤0.01% |
1,042
-97,600
| -99% | -$2.53M |
|
2837
Bakkt Holdings
BKKT
$135M
| $26K | ﹤0.01% |
103
-361
| -78% | -$91.1K |
|
2838
iBio
IBIO
$16.5M
| $25K | ﹤0.01% |
33
-45
| -58% | -$34.1K |
|
2839
Insmed
INSM
$31B
| $23K | ﹤0.01% |
817
-10,161
| -93% | -$286K |
|
2840
PubMatic
PUBM
$389M
| $23K | ﹤0.01% |
+600
| New | +$23K |
|
2841
Transmedics
TMDX
$3.72B
| $22K | ﹤0.01% |
677
-2,670
| -80% | -$86.8K |
|
2842
Zentalis Pharmaceuticals
ZNTL
$116M
| $22K | ﹤0.01% |
+417
| New | +$22K |
|
|
SREV
2843
DELISTED
ServiceSource International, Inc.
SREV
| $22K | ﹤0.01% |
15,419
+4,291
| +39% | +$6.12K |
|
2844
The Ensign Group
ENSG
$9.72B
| $21K | ﹤0.01% |
+243
| New | +$21K |
|
|
VERV
2845
DELISTED
Verve Therapeutics
VERV
| $21K | ﹤0.01% |
+351
| New | +$21K |
|
2846
NeueHealth
NEUE
$60.7M
| $21K | ﹤0.01% |
+15
| New | +$21K |
|
2847
Installed Building Products
IBP
$7.18B
| $20K | ﹤0.01% |
160
-12,194
| -99% | -$1.52M |
|
2848
Lifestance Health
LFST
$2.15B
| $20K | ﹤0.01% |
+700
| New | +$20K |
|
2849
Merus
MRUS
$5.03B
| $20K | ﹤0.01% |
+951
| New | +$20K |
|
2850
Dyne Therapeutics
DYN
$1.89B
| $19K | ﹤0.01% |
+912
| New | +$19K |
|